Brinks (BCO) vs CryoPort (CYRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CryoPort (CYRX) has outperformed Brinks (BCO) over the past year, gaining 77.0% versus a loss of 9.7%. Over five years, BCO leads with a +64.5% price change compared with -75.3% for CYRX. Brinks is the larger company by market cap ($4.23 billion vs $849.4 million), about 5.0 times the size.
Brinks pays a dividend yielding 0.99%, while CryoPort does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BCO | CYRX |
|---|---|---|
| Share price | $102.68 | $16.77 |
| Market cap | $4.23B | $849.39M |
| 1-day change | +0.60% | -3.34% |
| YTD return | -12.56% | +80.73% |
| 1-year return | -9.70% | +77.04% |
| 5-year return | +64.47% | -75.31% |
| P/E ratio (TTM) | 23.82 | — |
| Forward P/E | 9.92 | — |
| EPS (TTM) | $4.31 | $-0.81 |
| Dividend yield | 0.99% | 0.00% |
| Annual dividend | $1.02 | $0.00 |
| Revenue (latest FY) | $5.26B | — |
| Revenue growth (YoY) | +4.97% | — |
| Net income (latest FY) | $199.70M | — |
| Gross margin | 25.81% | — |
| Operating margin | 11.13% | — |
| Net margin | 3.80% | — |
| 52-week high | $136.37 | $18.36 |
| 52-week low | $91.05 | $7.61 |
| Distance from 52-week high | -24.70% | -8.66% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +42.51% | +17.29% |
| Average volume | 478.05K | 632.63K |
| Shares outstanding | 41.18M | 50.65M |
| Employees | 63,600 | 684 |
| Sector | Industrials | Health Care |
| Industry | Integrated Freight & Logistics | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Brinks is about 5.0 times larger than CryoPort by market value ($4.23B vs $849.39M).
- CYRX has outperformed BCO by 86.7 percentage points over the past year.
- The two companies sit in different sectors: Brinks in Industrials and CryoPort in Health Care.
About Brinks
BCO stock →The Brink's Company provides cash and valuables management, digital retail solutions (DRS), and automated teller machines (ATM) managed services in North America, Latin America, Europe, and internationally. The company offers cash-in-transit services, such as armored vehicle transportation of cash and coin; cash replenishment and treasury management of automated teller machines; international transportation, pick-up, packaging, customs clearance, secure vault storage, and inventory management of high-value commodities and goods; and counting, sorting, wrapping, check imaging, cashier balancing, counterfeit detection, account consolidation, and electronic reporting cash management services.
Industrials · Integrated Freight & Logistics · 63,600 employees
About CryoPort
CYRX stock →Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.
Health Care · Biotechnology: Pharmaceutical Preparations · 684 employees
BCO vs CYRX FAQ
Which is bigger, Brinks or CryoPort?
Brinks (BCO) is larger, with a market capitalization of $4.23B compared with $849.39M for CryoPort (CYRX).
Which stock has performed better over the past year, BCO or CYRX?
CYRX returned +77.04% over the past 12 months, compared with -9.70% for BCO (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Brinks or CryoPort?
Brinks pays a dividend yielding 0.99%, while CryoPort does not currently pay a regular dividend.
Are Brinks and CryoPort in the same industry?
No. Brinks is in the Industrials sector, while CryoPort is in Health Care.